Trump reversed a Biden order that sought to lower drug prices and make gene and cell therapies for cancer and other disease treatment available to Medicaid patients.
Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded collaboration with Michel ...